3.04 Listener Questions & MedTwitter and Risk Benefit Profile of Ramucirumab with Dr. Bishal Gyawali
July 24, 2020
310
11
3.55%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Vinay Prasad Md Mph Episodes Around July 24, 2020
See what was published immediately before and after this episode.
1:31:47Now Playing3.04 Listener Questions & MedTwitter and Risk Benefit Profile of Ramucirumab with Dr. Bishal Gyawali
YouTube Description
as posted by the channelThis week we respond to several questions sent in by listeners and then we interview Dr. Bishal Gyawali of Queen's University in Kingston, Ontario, Canada on MedTwitter, other recent events, and his recently published paper titled "Assessing the risk-benefit profile of ramucirumab in patients with advanced solid tumors: A meta-analysis of randomized controlled trials".
Ramucirumab: doi.org/10.1016/j.eclinm.2020.100458
Back us on Patreon! www.patreon.com/plenarysession
Vinay Prasad
HemeOnc Doctor & Associate Professor
Host of Plenary Session Podcast
Twitter @vprasadmdmph
Links & Promotions
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.